Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Anal Cancer Metastatic × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 794 Pancreatic Neoplasms 534 Carcinoma, Hepatocellular 491 Stomach Neoplasms 462 Esophageal Neoplasms 302 Rectal Neoplasms 261 Colonic Neoplasms 232 Breast Neoplasms 183 Liver Neoplasms 173 Neoplasms 171 Carcinoma, Non-Small-Cell Lung 162 Lung Neoplasms 155 Cholangiocarcinoma 139 Ovarian Neoplasms 132 Gastrointestinal Neoplasms 120 Esophageal Squamous Cell Carcinoma 113 Neoplasm Metastasis 111 Prostatic Neoplasms 91 Melanoma 91 Biliary Tract Neoplasms 87 Uterine Cervical Neoplasms 76 Endometrial Neoplasms 75 Head and Neck Neoplasms 70 Squamous Cell Carcinoma of Head and Neck 65 Urinary Bladder Neoplasms 58 Carcinoma, Renal Cell 55 Sarcoma 50 Adenocarcinoma Of Esophagus 49 Triple Negative Breast Neoplasms 48 Anus Neoplasms 45

Interventions

trifluridine tipiracil drug combination 1 reolysin 1 atezolizumab 1 Gemcitabine 1 Albumin-Bound Paclitaxel 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07280377 2025-12-12

GOBLET

Oncolytics Biotech

Phase 1/2 Recruiting

Gastrointestinal

Anal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡